Introduction
The active metabolite of vitamin D, 1 ,25-dihydroxyvitamin D [1 ,25-(OH)2-D], plays an important role in the pathogenesis of hypercalcemia associated with human granulomatous disease (1) (2) (3) (4) (5) (6) , and may have significant effects on the immune response in these diseases (7) . Macrophages and lymphocytes at the site of tissue inflammation can metabolize 25-hydroxyvitamin D (25-OH-D)' to 1,25-(OH)2-D (8, 9) , suggesting that 1,25-(OH)2-D has important local immunoregulatory effects. In vitro, 1,25-(OH)2-D stimulates macrophage differentiation and hydrogen peroxide production (10) (11) (12) , inhibiting mycobacterial growth in macrophages infected with Mycobacterium tuberculosis (13, 14) . Although some evidence suggests that 1,25-(OH)2-D inhibits antigen-stimulated lymphocyte proliferation (15, 16) and lymphokine production (17) , stimulatory effects on these processes have also been observed (18, 19) . Despite the in vitro data indicating a potential immunomodulatory role for 1,25-(OH)2-D in granulomatous diseases, direct evidence for the accumulation of 1,25-(OH)2-D at inflammatory sites and immunoregulation by the hormone at these sites is lacking.
Tuberculous pleuritis provides an excellent model for studying the role in vivo of factors that modulate the cell-mediated immune response. Inflammatory cells and pleural fluid are readily obtained from the site of disease activity, and immunologic reactivity against the tubercle bacillus is compartmentalized in the pleural space. The frequency of purified protein derivative (PPD)-reactive T-lymphocytes is higher in pleural fluid than in peripheral blood (20), and interferongamma, a lymphokine with antimycobacterial activity, is selectively concentrated in the pleural space (21) . In than serum (67±9 pg/ml versus 33±6 pg/ml; P < 0.001). In non-tuberculous effusions, mean 1,25-(OH)2-D concentrations in pleural fluid and serum are not significantly different (20±6 pg/ml vs. 33±13.7 pg/ml; P = 0.56).
tration of total hormone in pleural fluid was 100% higher than that in serum. In three additional patients with nontuberculous effusions, 1,2540H)2-D levels in pleural fluid were 8, 22, and 23 pg/ml. Serum samples were not available in these three cases.
To determine whether the transpleural gradient of 1,25-(OH)2-D in tuberculous pleuritis resulted from elevated levels ofprotein with 1,254OH)2-D binding capacity in pleural fluid, protein and albumin concentrations in serum and pleural fluid of these patients were examined. Mean total protein concentrations in pleural fluid and serum were 5.3 and 6.9 g/dl, respectively (P < 0.001). Mean albumin levels in these two compartments were 2.5 and 3.7 g/dl, respectively (P < 0.002). Thus, compared to serum, total protein and albumin levels were significantly reduced in pleural fluid, suggesting that albumin, which normally binds 15-25% .of total 1,25-OH)2-D (25) (Fig. 4 B) . In three pleural fluid-derived PPD-reactive lines (data not shown) and in two pleural fluid-derived T lymphocyte clones, 1,25-(OH)2-D3 inhibited T-cell proliferation at concentrations of 10-9 M (Table I). Tuberculous pleuritis is characterized by a marked local hypersensitivity response to mycobacterial antigens, even though the bacillary load is generally low (32, 33) . In this setting, lymphocyte proliferation and lymphokine production may result in an uncontrolled inflammatory response that causes undue host tissue destruction. 1,25-(OH)2-D may limit this response by acting as a brake on the immune system. We have demonstrated that 1,25-(OH)2-D3 has the potential to exert powerful, receptor-mediated inhibitory effects on antigen-induced proliferation by pleural fluid lymphocytes, at the level of freshly isolated cells, antigen-reactive lines, and Tlymphocyte clones derived from a single cell. Under culture conditions utilizing 10% human serum, antiproliferative effects were observed at total 1,25-(OH)2-D3 concentrations of 10-`0 M. Since -4% oftotal 1 ,25-(OH)2-D3 is free under these conditions (24) , free 1,25-(OH)2-D levels would be in the range of 4 X 10-12 M or 1,600 fg/ml. In tuberculous pleuritis, mean free 1,25-(OH)2-D concentrations in pleural fluid were over 600 fg/ml and thus could be high enough to exert an immunoinhibitory effect in vivo. Free 1,25-(OH)2-D concentrations in the local microanatomic environment of the inflammatory site are likely to be higher than those measured in pleural fluid.
1 ,25-(OH)2-D stimulates macrophage differentiation (1 1), giant cell formation (10) , and hydrogen peroxide production (12) . In addition, 1,25-(OH)2-D has recently been shown to inhibit growth of Mycobacterium tuberculosis in macrophages (13, 14) . It is intriguing to speculate that elevated 1,25-(OH)2-D concentrations in the pleural space may facilitate the ingestion and elimination of mycobacteria through enhancing macrophage function. Thus, 1,25-(OH)2-D has the potential both to stimulate cell-mediated immune defenses against mycobacteria while limiting host tissue destruction due to uncontrolled lymphocyte proliferation. Further studies of the complex interactions between 1,25-(OH)2-D, M. tuberculosis and the human immune system will provide important insight into the immunoregulatory role of this hormone in human granulomatous diseases.
